Transcription of Table 2d. Ivermectin: Selected Clinical Data
{{id}} {{{paragraph}}}
COVID-19 Treatment Guidelines 99 Antiviral Drugs That Are Approved or Under Evaluation for the Treatment of COVID-19 Last Updated: December 16, 2021 Summary RecommendationsRemdesivir is the only drug that is approved by the Food and Drug Administration for the treatment of COVID-19. In this section, the COVID-19 Treatment Guidelines Panel (the Panel) provides recommendations for using antiviral drugs to treat COVID-19 based on the available data. For more information on these antiviral agents, see Table See Therapeutic Management of Hospitalized Adults with COVID-19 for recommendations on using remdesivir for the treatment of There is insufficient evidence for the Panel to recommend either for or against the use of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted Clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin in the treatment of The Panel recommends against the use of systemic interferon beta for the treatment of hospitalized patients with COVID-19 (AI).
Dec 16, 2021 · COVID-19 Treatment Guidelines 158 Table 2d. Ivermectin: Selected Clinical Data. Last Updated: December 16, 2021. The Panel has reviewed other clinical studies of IVM for the treatment of COVID-19.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}